Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
GEMoaB Monoclonals

GEMoaB Monoclonals

GEMoaB Monoclonals is a cellular immunotherapies for cancer.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 19 Sep, 2022
"prospector:1906:1371060"
Katrina-Kay Pettitt profile picture
Katrina-Kay Pettitt
edited on 19 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Industry
Engineering
Engineering
Edits on 12 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 12 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Is a
Organization
Organization
Edits on 8 Apr, 2022
"Patent autocalculation"
Golden AI profile picture
Golden AI
edited on 8 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patents assigned (count)
8
Edits on 3 Jul, 2021
"Approved suggestion from source: http://gemoab.com"
Melanie Manipula profile picture
Melanie Manipula
approved a suggestion from Golden's AI on 3 Jul, 2021
Edits made to:
Topic thumbnail

GEMoaB Monoclonals

Cellular immunotherapies for cancer

Edits on 14 Jun, 2021
"Created via: prospector:324:159450"
Erin Scherfner profile picture
Erin Scherfner
created this topic on 14 Jun, 2021
Edits made to:
Infobox (+4 properties)
Description (+35 characters)
Topic thumbnail

 GEMoaB Monoclonals

Cellular immunotherapies for cancer

Infobox
Is a
Company
Company
Industry
Biomedical engineering
Biomedical engineering
Website
http://gemoab.com
Country
Germany
Germany

Find more companies like GEMoaB Monoclonals

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.